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Abstract
Kv7 channels determine the resting membrane potential of neurons and regulate their excitability. Even though dysfunction of
Kv7 channels has been linked to several debilitating childhood neuronal disorders, the ontogeny of the constituent genes, which
encode Kv7 channels (KNCQ), and expression of their subunits have been largely unexplored. Here, we show that developmen-
tally regulated expression of specific KCNQ mRNA and Kv7 channel subunits in mouse and human striatum is crucial to the
functional maturation of mouse striatal neurons and human-induced pluripotent stem cell-derived neurons. This demonstrates
their pivotal role in normal development and maturation, the knowledge of which can now be harnessed to synchronise and
accelerate neuronal differentiation of stem cell-derived neurons, enhancing their utility for disease modelling and drug discovery.
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Introduction
Kv7 channels [4] are sub-threshold, voltage-gated potassium
ion channels that are widely expressed in mammalian central
and peripheral neurons [5]. They were first described in sym-
pathetic neurons [4] and have subsequently been identified in
a variety of neurons including medium spiny neurons (MSNs)
of the striatum [33], sensory nociceptive structures [6, 27],
hippocampal CA1 pyramidal cells [14, 31, 32], as well as in
the substantia nigra [34]. Neuronal Kv7 channels are assem-
bled of two Kv7.2 and two Kv7.3 subunits, most commonly,
but not invariably [18, 40]. Functionally, they help to maintain
and stabilise the neuronal resting membrane potential (Vm),
thereby controlling neuronal excitability and action potential
threshold [11]. In mammals, Kv7 channels, and/or their con-
stituent subunits, are developmentally upregulated during ear-
ly post-natal life [13, 38, 41], with associated changes in Vm
[23] and excitability [30]. Kv7 channels have also been re-
ported to play roles in survival, maturation and synapse devel-
opment in embryonic stem cell-derived and human-induced
pluripotent stem cell (hiPSC)-derived neurons [35, 44]. Being
a critical determinant of neuronal excitability, regulated ex-
pression of Kv7 channels during neuronal differentiation and
maturation ought logically to be vital for the progressive
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hyperpolarization of Vm and its stabilisation below the thresh-
old for voltage-gated Na+ channel activation/inactivation [5],
during early development. However, the importance of Kv7
channels in pre-natal neuronal development and maturation
remains largely unexplored. In the present experiments, we
have considered how far the developmental expression of
Kv7 channels might contribute to the functional maturation
of striatal neurons. Within the striatum, mature MSNs play an
important role in the control of movement and in a range of
cognitive and behavioural functions [7, 12] and show promi-
nent degeneration in Huntington’s disease (HD) [39]. They
display conspicuous Kv7 currents which contribute to their
Vm and action potential threshold to regulate their excitable
behaviour [8, 33].
Thus, the present study was designed to test firstly the
hypothesis that the functional neuronal development of mouse
embryonic striatal neurons, isolated at embryonic day (E)13,
E15 and E17 and cultured in vitro for up to 16 days, is asso-
ciated with enhanced expression and activity of Kv7 channels.
Once this was established inmouse striatum, the ontogenies of
Kv7 subunits were determined in developing and adult stria-
tum of the human brain. We then investigated the functional
and molecular expression of Kv7 channels during neuronal
differentiation and maturation of hiPSC-derived neurons.
Finally, the idea that forced co-expression of Kv7.2 and
Kv7.3 might represent a novel method by which to accelerate
the functional maturation of neurons in vitro was tested using
two independent hiPSC lines. Taken together, these data show
that progressive expression of Kv7 channels during develop-
ment of striatal neurons leads to hyperpolarization and in-
creased excitability in vivo and that forced expression of
Kv7 channels results in enhanced functional maturation of
stem cell-derived neurons in vitro.
Methods
Isolation and culture of embryonic mouse striatal
neurons
Striata were dissected frommouse embryos at stages E13, E15
and E17 and placed into hibernate medium (Invitrogen Life
Technologies, Paisley, Strathclyde, UK), gently triturated
using a P1000 pipette and then centrifuged at 1000 rpm for
2 min. The resultant tissue pellets were resuspended in 1–
3 mL of accutase (PAA Laboratories GmbH Yeovil,
Somerset, UK) with 200 U/mL DNase1 (Sigma-Aldrich,
Poole, Dorset, UK) and incubated at 37 °C with regular gentle
trituration, for 10–30 min, before the addition of equal vol-
umes of Advanced DMEM/F12 medium (Invitrogen Life
Technologies), and final mechanical disaggregation. The cell
suspensions were centrifuged at 110g for 5 min and the
pelleted cells were resuspended in 2–3 mL differentiation
medium with the following composition: Advanced DMEM/
F12 (Invitrogen Life Technologies) adjusted to 1.8 mMCaCl2
(Sigma-Aldrich) and supplemented with 2 mM L-glutamine
1% penicillin/streptomycin (Invitrogen Life Technologies),
0 .5 mM valproic ac id (Sigma-Aldr ich) and 2%
NeuroBrew21 (with vitamin A, MACS Miltenyi Biotec,
Bisley, Surrey, UK). Finally, neurons were plated onto 1 mg/
mL poly-D-lysine (PDL, Sigma-Aldrich)-coated 13-mm glass
coverslips (VWR International, Lutterworth, Leicestershire,
UK) at a density of approximately ~ 1 × 105 cells/coverslip
and were cultured in differentiation medium for up to 16 days
at 37 °C in a humidified atmosphere of 5% CO2/95% air.
Differentiation medium was changed every 2–3 days.
Striatal neurons were used for further experimentation from
1 day post-plate down (dpp) onwards.
Human iPSC culture, differentiation and transfection
Two hiPSC lines were employed in this study. Firstly, the
CS83iCTR33 (CTR33Qn1) line which was derived from an
unaffected sibling of a patient with Huntington’s disease
(HD), with genotyped CAG repeat lengths of 33 and 18 in
the HTT gene; this line was reprogrammed using a non-
integrating strategy and was developed as a ‘control’ line for
a related study on Huntington’s disease hiPSC characterisation,
similar to that already published for integrating HD hiPSC lines
[25]. Secondly, the 34D6 line [2] was derived from a ‘control’
patient and re-programmed using integrating vectors, a kind
gift of Prof. Siddharthan Chandran, University of Edinburgh.
hiPSC lines were cultured in the pluripotent state using
mTeSR™1 (Stem Cell Technologies, Grenoble, France) on
BD Matrigel-coated plates (BD Biosciences, Oxford, Oxon,
UK), with dispase passaging following the manufacturer’s
instructions (Stem Cell Technologies). hiPSCs were differen-
tiated to neural progenitors using an in-house, patented differ-
entiation protocol (PCT/GB2014/053064) previously de-
scribed [37], that is similar to that described for hES cells
[26]. To generate ventral forebrain neural progenitors,
hiPSCs were plated onto Matrigel-coated glass coverslips
and transferred into SLI medium (Advanced DMEM/F12,
supplemented with 2 mM L-glutamine, 1% penicillin/strepto-
mycin, 2% NeuroBrew21 (without vitamin A), 10 μM
SB431542 (Abcam, Cambridge, Cambridgeshire, UK),
1 μM LDN 193189 (Stemgent, Cambridge, MA, USA) and
1.5 μM IWR1 (Tocris Bioscience, Abingdon, Oxon, UK); this
point was designated as 0 dpp. Cells were cultured for 4 days
in SLI medium with medium changed daily. At 5 dpp, cells
were treated with 10 μM Y-27632 (Abcam) for 1 h prior to
passage using accutase and replating on Matrigel-coated
plates with a split ratio of 1:2. At 8 dpp, cells were passaged
as above and the medium was switched from SLI to LI medi-
um (Advanced DMEM/F12, supplemented with 2 mM L-glu-
tamine, 1% penicillin/streptomycin, 2% NeuroBrew21
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(without vitamin A), 250 nM LDN 193189 and 1.5 μM
IWR1). The medium was changed daily until day 16 dpp,
when neural progenitors were harvested by accutase (GE
Healthcare Life Sciences, Little Chalfont, UK) treatment and
centrifugation at 110g, and the cell pellets resuspended as a
single cell suspension, and cultured on Matrigel-coated cov-
erslips at a density of approximately 1 × 105 cells/coverslip in
SCM1 differentiation medium (Advanced DMEM/F12, sup-
plemented with 2 mM L-glutamine, 1% penicillin/streptomy-
cin, 2% NeuroBrew21 (with vitamin A), 2 μM PD0332991
(Tocris Bioscience), 10μMDAPT (Tocris Bioscience), 10 ng/
mL BDNF (MACS Miltenyi Biotec), 1 μM LM22A4 (Tocris
Bioscience), 10 μM forskolin (Tocris Bioscience), 3 μM
CHIR 99021 (Tocris Bioscience), 300 μM GABA (Tocris
Bioscience), 1.8 mM/L CaCl2, 200 μM ascorbic acid
(Sigma-Aldrich)). At 23 dpp, SCM1 medium was exchanged
for SCM2 (1:1 Advanced DMEM/F12: Neurobasal A
(Invitrogen Life Technologies), supplemented with 2 mM L-
glutamine, 1% penicillin/streptomycin, 2% NeuroBrew21
(with vitamin A), 10 ng/mL BDNF, 1 μM LM22A4, 3 μM
CHIR 99021, 1.8 mM/L CaCl2, 200 μM ascorbic acid) and
cultured in SCM2 for up to 37 dpp with 50%medium changes
every 3–4 days.
Sixteen dpp CTR33Qn1 and 34D6-hiPSC-derived neural
progenitor cells were co-transfected with Kv7.2/7.3 cDNA
plasmid concatemer [42] and pmax®GFP (Lonza, Cologne,
Germany) at a ratio of 10:1 using the Amaxa Nucleofector
human stem cell kit (Lonza), following the manufacturer’s
protocols. As a control, a sham transfection was performed
using the empty vector. After transfection, the cells were plat-
ed and cultured in SCM1 on PDL- andMatrigel-covered glass
coverslips and, after incubation for 24 h, were transiently se-
lected with 800 μg/mL G418 (Sigma-Aldrich). SCM1 was
exchanged for SCM2 after 23 dpp and cells were cultured
for up to 37 dpp.
Electrophysiological recordings and analyses
Voltage and current recordings were made using conventional
patch-clamp in the whole-cell configuration [15, 37]. The bath
solution contained (in mM) 135 NaCl (Fisher Scientific UK
Ltd, Loughborough, Leicestershire, UK), 5 KCl (Fisher), 1.2
MgCl2 (Sigma-Alrich), 1.25 CaCl2 (Sigma-Aldrich), 10 D-
glucose (Fisher) and 5 N-2-hydroxyethylpiperazine-N′-2-
ethanesulfonic acid (HEPES, VWR International); pH was
adjusted to 7.4 using 5 M NaOH. The pipette solution
contained (in mM) 117 KCl, 10 NaCl, 11 HEPES, 2 Na2-
ATP (Sigma-Aldrich), 2 Na-GTP (Sigma-Aldrich), 1.2 Na2-
phosphocreatine (Sigma-Aldrich), 2 MgCl2, 1 CaCl2 and 11
ethylene-glycol-tetra-acetic acid (EGTA, Fisher); pH was ad-
justed to 7.2 with KOH. All electrophysiological studies were
performed using an Axopatch 200B amplifier and Digidata
1322A A/D interface (Axon Instruments, Forster City, CA,
USA) at a controlled room temperature of 22 ± 0.5 °C.
Recordings were digitised at 10 kHz and low-pass filtered at
2 Hz using an 8-pole Bessel filter. The patch-clamp data were
analysed using Clampfit 9.0, Microsoft Excel and Microcal
Origin 6.0 software.
Membrane potential (Vm) was recorded in current-clamp
mode. Mean (± SEM) membrane potential values were plotted
against dpp. Neurons were coded according to the type of sAP
activity that they demonstrated, defined as follows: (1) sponta-
neous action potentials (Spontaneous, at least 1 excursion that
overshoots 0 mV), (2) attempted spontaneous action potentials
(Attempting, significant excursions from resting Vm that did
not reach 0 mV) or (3) no action potentials (Quiet, no signifi-
cant excursions from restingVm). This then allowed neurons to
be categorised into the three separate groups for further detailed
analysis. Once Vm and spontaneous activity had been record-
ed, current was injected to hyperpolarize Vm to ca. − 70 mV
before 1 s current injection steps were imposed (from − 10 to +
180 pA) in order to induce action potentials. Input resistance
was measured from the voltage difference induced by the − 10-
pA current step to record induced action potential activity,
which was coded as none (no significant excursions from base-
line during injection), attempting single (significant excursions
from baseline that do not reach 0 mV), single (a single excur-
sion that overshoots 0 mV), attempted train (several excursions
but only 1 overshoots 0 mV) and train (several excursions, at
least 2 of that overshoot 0 mV).Where induced action potential
trains were recorded, a spike frequency analysis was per-
formed. Input resistance was measured from the voltage differ-
ence induced by the − 10-pA current step. Spike analysis was
performed on the first spike of an induced action potential train
using Clampfit 9; threshold was determined as the peak of the
3rd differential of voltage with respect to time during the up-
stroke of the action potential, and all other parameters are as
defined extensively elsewhere [1].
Na+ currents were recorded using a standard voltage-step
protocol (holding potential of − 70 mV followed by 80 ms
steps from − 120 to + 80 mV in increments of 10 mV). For
Na+ current inactivation curves, cells were stepped for 200 ms
to pre-pulse voltages of between − 120 and + 80 mV in 5 mV
step increments before being stepped for 200 ms to the test
potential of 0 mV. Cell capacitance and series resistance were
measured and compensated; series resistance was compensat-
ed 60–90%. Pipette resistances were 8–10 MΩ when filled
with the pipette solutions.
Conductances (G) for activation and inactivation were cal-
culated by dividing current by the appropriate driving force,
(Vc − ENa), where Vc = command potential, and ENa = +
66.7 mV. G/Gmax was plotted against voltage and fitted with
a Boltzmann equation using an iterative fitting routine:
G=Gmax ¼ 1= 1þ exp V50−V cð Þ=h½ 
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where Gmax is the extrapolated maximum conductance, Va50
and Vi50 are the voltages corresponding to half the maximum
conductance and h is the slope factor.
Multi-electrode arrays CTR33Qn1 hiPSCs at 16 dpp were
plated at a density of 150 × 103 cells/well onto poly-D-
lysine-coated, 24-well multi-electrode arrays (MEAs)
and cultured sequentially using the differentiation proto-
col as described above and in the previous study [37].
At 21 dpp, the medium was switched for a HEPES-
buffered physiological solution containing the following
(in mM): 130 NaCl, 3 KCl, 1 MgCl2, 2 CaCl2, 10 D-
glucose and 10 HEPES-NaOH at pH 7.4, and the MEAs
were placed onto the temperature-controlled (37 °C)
platform of a commercially available MEA workstation
(Multichannel Systems, Reutlingen, Germany). Each
well contained 12 electrodes, the activities of which
were recorded simultaneously before, during and follow-
ing manual addition of agonists, antagonists and toxins,
as defined in the text and legends. Data were band-pass
filtered between 100 and 2000 Hz and finally sampled
at 20 kHz using the acquisition software provided with
the device. During recordings, this software detected
single unit activity online and live displays of raw data,
spikes per second histograms, and detected spike wave-
forms were available. For analysis, raw data were con-
verted to a HDF5 file format, which was imported into
the MatLab environment in which custom-written anal-
ysis routines were coded. Spikes were redetected and
sorted, and time stamps were extracted allowing the
various plots shown here to be produced. Root mean
square recording noise levels were ~ 1.7 μV. Spikes
were detected using a threshold method (usually 5 SD
of the mean) that detected either rapidly rising or falling
events. Amplitudes of clearly resolvable spikes uncon-
taminated by significant levels of false detections varied
between 10 and 100 μV. The major source of this am-
plitude variation is likely to be the physical distance of
each detected neuron from the recording site. Typically,
spontaneous spiking activity could be detected on mul-
tiple electrodes within a single well and in 24-well
plates.
Gabazine hydrobromide (SR-95531) (Tocris Bioscience) at
5 μM was employed as a selective competitive antagonist of
GABAA receptors [37]. Retigabine dihydrochloride (LKT
Laboratories Inc., St Paul,MN, USA) at 10μMwas employed
as a selective opener of Kv7 channels [42]; XE991 (Sigma-
Aldrich) at (10 μM) was used as a selective blocker of Kv7
channels [40].
All data are expressed as mean ± SEM. Statistical compar-
isons of the means were performed using 2-way AVOVA or
Student’s t tests, as appropriate; differences were considered
significant at p < 0.05.
Human tissue collection, processing and data analysis
Adult motor cortical, caudate and putamen samples from 31- to
86-year-old donors were obtained from the Neurological Tissue
Bank of the Biobank-Hospital Clínic (IDIBAPS) following the
guidelines and approval of the local ethics committee (Hospital
Clínic of Barcelona’s Clinical Research Ethics Committee). Total
RNAwas isolated using TRI Reagent (Sigma-Aldrich) following
the manufacturer’s protocol. Human foetal tissue (CRL of 22–
54 mm) ranging in age from 7 to 9 weeks post-conception was
collected by donation of the products of elective termination of
pregnancy, within the MRC- and Welsh Government-sponsored
South Wales Initiative for Foetal Tissue Transplantation
(‘SWIFT’) programme, with full ethical approval (02/4446).
Tissue was collected directly into hibernation medium at 4 °C
and transported to Cardiff University where it was dissected
under category II culture conditions, according to a previously
published protocol [19]. Cortex and striatal primordia were dis-
sected in 0.9% saline solution with addition of 0.6% glucose
(hospital pharmacy) and stored individually in TRIzol
(Invitrogen Life Technologies) at − 80 °C until use. Total RNA
was isolated using TRI Reagent (Sigma-Aldrich) or TRIzol fol-
lowing themanufacturer’s protocol. Then, 10μL of total RNA at
a concentration of 200 ng/μL (2 μg in total) for each sample was
reverse-transcribed with random primers using High-Capacity
RNA-to-cDNA Kit (Invitrogen Life Technologies); 10 μL of
retro-transcription cocktail (2 μL of 10× RT buffer, 2 μL pf
Random primers,1 μL of dNTP mix; 1 μL MultiScribe reverse
transcriptase) was added to each sample (20 μL total volume).
After gentle mixing, samples were incubated for 10 min at room
temperature followed by 2 h at 37° C, 10 min on ice and 10 min
at 75° C; 10 ng of cDNAwas used to perform quantitative real-
time PCR (qPCR). PrimeTime qPCR assays were used as rec-
ommended by the provider (IDT Technologies, Leuven,
Belgium). RPL13A, B2M and HSP90 mRNA levels were used
as reference genes. qPCR was carried out with Premix Ex Taq
(Takara Clontech, Saint-Germain-en-Laye, France) in 6 μL of
final volume using CFX384-C1000 Thermal Cycler equipment
(Bio-Rad). Samples were run for 40 cycles (95 °C for 5 s, 60 °C
for 20 s). Relative gene expression values were calculated using
the 2−ΔΔCt [22] using Bio-Rad CFXmanager software (Bio-Rad,
Madrid, Spain). All data are expressed as mean ± SEM. Data
were analysed using GraphPad 4.02. Statistical comparisons of
the means were performed using two-tailed, unpaired t test; dif-
ferences were considered significant at p < 0.05.
Mouse tissue collection and processing
for microarrays and qPCR
C57/Bl6 mice (Charles River Laboratories, Les Oncins,
France) were maintained in standard conditions with
food and water ad libitum. All animal procedures were
approved by local committees, in accordance with the
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European Communities Council Directive (86/609/EU).
The day of pregnancy, determined by the first detection
of a vaginal sperm plug in daily inspection, was consid-
ered embryonic day (E) 0.5. Briefly, brains were re-
moved, frozen and embedded before sections were cut
using a cryostat, and after cresyl violet staining, the
two different zones of the lateral ganglionic eminence
(LGE) germinal zone (GZ) and mantle zone (MZ) were
microdissected using the Leica Laser Microdissection
Microscope D7000. RNA extraction of the collected
samples was carried out with the RNeasy Micro Kit
(Qiagen). Microarrays were run using the Affymetrix
MouseGene ST v1.1 chip to analyse 32 mRNA samples
(5–4 samples per condition). To validate the dynamics of
Kv7.2 (KCNQ2) and Kv7.3 (KCNQ3) gene expression
during mouse embryonic development, mRNA levels of
both channels were analysed by qPCR at different devel-
opmental stages (E12.5, E14.5, E16.5 and E18.5) and in
the different striatal zones (LGE for E12.5, GZ and MZ
for the other stages). Expression of mRNA encoding
KNCQ channels in embryonic mouse striatal (mSTM)
neurons was determined by qPCR (see above, for condi-
tions). All data are expressed as mean ± SEM. Data were
analysed using GraphPad 4.02. Statistical comparisons
were made by two-way analysis of variance (ANOVA)
followed by Bonferroni post-test. Values of p < 0.05 were
considered statistically significant.
Immunocytochemistry
Cells were fixed with 4% paraformaldehyde in PBS
(Invitrogen Life Technologies) for 15 min at 37 °C.
Cells were washed (3×) for 5 min, blocked and
permeabilised using PBS containing 1% BSA (w/v)
0.1% Tween-20 for 1 h at room temperature before being
incubated overnight at 4 °C in rabbit primary antibody
solutions (anti-KCNQ2 at 1:100 (Abcam, ab22897); anti-
KCNQ3 at 1:100 (Aviva Systems Biology Corporation,
San Diego, CA, USA, OAAF00246)). Controls, where
primary antibodies were omitted, were included for all
experimental sets. After overnight incubation, the prima-
ry antibody solution was removed and the cells were
washed for 5 min in PBS (3×) before incubation for
1 h with fluorophore-conjugated secondary antibody
(Alexa Flour-488, goat anti-rabbit, Life Technologies) at
room temperature in the dark. Nuclear staining employed
Hoechst stain (Life Technologies) at 1:5000 in PBS.
Cove r s l i p s we r e moun t ed i n F luo romoun t G
(eBioscience, Hatfield, Hertfordshire, UK) and imaged
using Olympus BX61 with SIS F-view charge-coupled
device (CCD) camera and AnalySIS imaging software
(Olympus, Southend-on-Sea, Essex, UK).
Results
Development of Vm and expression of Kv7.2
and Kv7.3 subunits during in vivo and in vitro
maturation of mouse striatal neurons
During the first dpp in vitro, meanVm values of mouse striatal
neurons isolated at embryonic stages E15 and E17 were sig-
nificantly different (p < 0.001) from that of E13 neurons, but
not significantly different from each other: E13 = − 24.8 ±
2.3 mV (n = 26), E15 = − 40.0 ± 2.2 mV (n = 12) and E17 =
− 47.2 ± 2.4 mV (n = 9). These data suggest that the most im-
portant stage in the early development of a hyperpolarized Vm
in vivo takes place between E13 and E15 (Fig. 1a, b). Over the
next 6 dpp, mouse striatal neurons isolated at all three stages
displayed a steady hyperpolarization to between − 50 and −
60 mV, with only modest hyperpolarization occurring there-
after up to 15 dpp (Fig. 1a, b). Mean Vm values of each group,
at either 7 or 15 dpp, were not significantly different from each
other (Fig. 1b).
Since one of the most important mechanisms responsible
for setting and maintaining of Vm in the neurons is represent-
ed by Kv7 channels [3, 4, 18, 24], the expression of the Kv7.2
and Kv7.3 protein subunits was determined using immunocy-
tochemistry in neurons isolated at E13 and cultured for up to
14 dpp. During in vitro differentiation and maturation, neu-
rons became more complex and demonstrated a time-
dependent expression of both Kv7.2 (Fig. 1c, left panel) and
Kv7.3 (Fig. 1c, right panel) in processes and somata; no stain-
ing was observed in the negative control when the primary
antibody was omitted (not shown).
Ontogeny of KCNQ (Kv7) subunits in developing
mouse and human striatum
Having established that Vm and level of Kv7 channel subunit
expression were subjects to developmental regulation, the on-
togenies in vivo of the genes KCNQ2 and KCNQ3 (which
encode Kv7.2 and Kv7.3 subunits, respectively) were deter-
mined in laser-microdissected mouse striata. Developmental
time points of E12.5 (LGE) through E18.5 (GZ andMZ) were
employed. For KCNQ2 mRNA in vivo, two-way AVOVA
highlighted an overall difference between GZ and MZ (p <
0.01), with a specific enrichment observed at E14.5 (p < 0.02,
Fig. 2a). For KCNQ3mRNA, a similar analysis demonstrated
regional differences (p < 0.001), with enrichments at E14.5 (p
< 0.05), E16.5 (p < 0.01) and E18.5 (p < 0.01, Fig. 2b).
Comparisons of mRNA levels in each zone with LGE dem-
onstrated that the KCNQ2 did not significantly alter during
development in either zone (Fig. 2c). In contrast, KCNQ3
steadily increased during development in the MZ (Fig. 2d).
Thus, consistent with the electrophysiological observations,
these data show that mRNA encoding both KCNQ2 and
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KCNQ3 becomes enriched in the post-mitotic MZ.
Furthermore, they also suggest that the developmentally up-
regulated function of Kv7 channels is not a direct consequence
of differential transcription of the KCNQ2 gene but that of
genes encoding other Kv7 subunits, such as KCNQ3 (as
shown in Fig. 2b, d), or even KCNQ4 and KCNQ5 (Fig. 3).
Further investigation of this idea was carried out by
employing qPCR to quantify the expression of other KCNQ
genes in mouse striatal neurons isolated between E13 and E17
and cultured for up to 7 DIV which, as a group, increased
significantly (p < 0.001) between 1 and 7 dpp. Specifically,
at 1 dpp, KCNQ2 mRNA was expressed at similar levels
across all developmental time points (Fig. 3a). However,
KCNQ3 mRNA (along with those for KCNQ4 and KCNQ5)
was upregulated between E13 and E15 (p < 0.05 for KCNQ3
and KCNQ5, p < 0.01 for KCNQ4, Fig. 3a); thereafter,
KCNQ4 and KCNQ5 expression declined whilst KCNQ3
was sustained (Fig. 3a). During differentiation and maturation
in vitro, a slightly different early pattern of mRNA expression
was observed, with both KCNQ2 and KCNQ3 mRNA in
mouse striatal neurons isolated at E13 increasing between 1
and 7 dpp (p < 0.05, Fig. 3b); mRNA encoding KCNQ4 and
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indicated) protein expression by
immunocytochemistry in E15
mouse striatal neurons during in
vitro maturation at 1, 7 and
14 dpp
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Fig. 2 Ontogeny of KCNQ2 and KCNQ3 mRNA expression in
developing mouse striatum in vivo. a KCNQ2 mRNA expression
during mouse striatal development in vivo. In a and b, mRNA levels
were determined in laser-microdissected mouse striatal regions by
qPCR and were normalised to the house-keeping genes (18S/β-actin)
using the ΔΔCt method. By two-way ANOVA, there was a significant
difference between KCNQ2 mRNA in mantle zone (MZ) and germinal
zone (GZ), **p < 0.01, with a significant enrichment in MZ at E14.5,
asterisk above the MZ bar, *p < 0.05. b KCNQ3 mRNA expression
during mouse striatal development in vivo. By two-way ANOVA, there
were significant regional differences, ***p < 0.001, with significant
enrichments in the MZ at E14.5, E16.5 and E18.5, asterisks above the
MZ bars, *p < 0.05, **p < 0.01. c KCNQ2 mRNA expression during
mouse striatal development in vivo. For c and d, mRNA levels in laser-
microdissected mouse striatal regions were determined by qPCR and
were normalised to the house-keeping genes (18S/β-actin) using the
ΔΔCt method. Data were analysed by one-way ANOVA with Tukey’s
post hoc test, and showed that, compared to LGE, KCNQ2mRNA levels
in each zone did not significantly alter during development in either zone.
d KCNQ3mRNA expression during mouse striatal development in vivo.
Data were analysed by one-way ANOVAwith Tukey’s post hoc test, and
showed that, compared to LGE, KCNQ3mRNA in theMZwas shown to
increase steadily during development. *p < 0.05, ***p < 0.001,
****p < 0.0001
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KCNQ5 demonstrated no significant changes during in vitro
differentiation (Fig. 3b).
Finally, we sought to determine whether the overall pattern
of KCNQ/Kv7 expression that was observed in mouse was
reflective of the situation in human development. To this
end, cryosections were cut from human foetal brain samples
collected 7–9 weeks post-conception, when developing stria-
tum is effectively the whole ganglionic eminence (WGE) and
KCNQ mRNA levels compared with post-mortem adult stria-
tum. KCNQ2 mRNAwas expressed at similar levels between
the stages (Fig. 3c). Strikingly, and similar to the pattern seen
in developing mouse striatum, KCNQ3 was significantly
enriched in the striatum, as were KCNQ4 and KCNQ5
(Fig. 3c). These data, which demonstrate the enrichment of sub-
units which constitute Kv7 channels in the post-mitotic neuronal
compartments of the developing striatum ofmouse and human in
vivo, and the broadly similar pattern which is seen when mouse
striatal neurons are differentiated in vitro, correlate well with the
functional data showing developmentally regulated progressive
hyperpolarization of Vm (see Fig. 1).
Expression of KCNQ and Kv7 channel subunits
during neuronal differentiation of hiPSCs
Although there have been observations that Kv7 channels
contribute to the excitability of hiPSC-derived neurons [44],
c
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Fig. 3 Ontogeny of KCNQ
mRNA expression in
developing mouse and human
striatum. a KCNQ mRNA
expression in mouse striatal
neurons during development in
vivo. mRNA levels were
determined in mouse striatal
neurons isolated at E13, E15 and
E17 by qPCR and were
normalised to the house-keeping
genes (18S/β-actin) using the
ΔΔCt method. By one-way
ANOVA (Tukey’s post hoc), there
were significant differences
between KCNQ mRNA at E15
and E17 with its own control at
E13, p < 0.05. b KCNQ mRNA
expression in E13 mouse striatal
neurons during in vitro
differentiation and maturation. By
one-way ANOVA (Tukey’s post
hoc), there were significant
differences of KCNQ2 and
KCNQ3 mRNA between 1 and
7 dpp, p < 0.05. c KCNQ mRNA
expression during human striatal
development in vivo. mRNA
levels in human striatal regions
dissected from cryosections were
determined by qPCR and were
normalised to house-keeping
genes (RPL13A and HSP90AB1)
using the ΔΔCt method. By
unpaired Student’s t test, there
were significant differences
between whole ganglionic
eminence (WGE, 7–9weeks post-
conception) and adult striatum
expression of KCNQ3, KCNQ4
and KCNQ5 mRNA, *p < 0.05
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none have investigated directly the correlation between ex-
pression of Kv7 subunits, hyperpolarization of Vm and excit-
ability during differentiation of hiPSCs, especially those pre-
patterned to ventral forebrain precursors. Therefore, using the
hiPSCs pre-patterned by an established technique of dual
SMAD and Wnt inhibition [20, 26, 37], a detailed
determination of both the expression of KCNQ mRNA and
Kv7 subunits in these developing striatal-like neurons was
performed using the control hiPSC line, CS83iCTR33Qn1
(CTR33Qn1). KCNQ2 and KCNQ5 mRNA both increased
early (23 dpp), whilst KCNQ3 and KCNQ4 showed no signif-
icant differences during the differentiation protocol. Uniquely,
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Fig. 4 Ontogeny of KCNQ
mRNA and Kv7 channel
protein expression during
neuronal differentiation of
CTR33Qn1 hiPSC-derived
neurons. a Ontogeny of KCNQ2
(upper left), KCNQ3 (upper
right), KCNQ4 (lower left) and
KCNQ5 (lower right) mRNA
expression during neuronal
differentiation of CTR33Qn1
hiPSC-derived neurons from pre-
patterned forebrain progenitors
(16 dpp) to maturation (37 dpp).
mRNA levels were determined by
qPCR, were normalised to the
house-keeping genes (B2M,
RPL13A and HSP90AB1) using
the 2−ΔΔCt method and expressed
as a level relative to 16 dpp. Data
were analyses by one-way
AVOVA followed by Tukey’s
post hoc test. Differences from
16 dpp are shown, **p < 0.01,
***p < 0.001. b Comparison of
mean ΔCt values of each KCNQ
during CTR33Qn1 hiPSC
neuronal differentiation. KCNQ2
and KCNQ3 values were
significantly lower than KCNQ4
or KCNQ5, indicating that the
former are expressed at a higher
level than the latter. Two-way
ANOVA, p < 0.001. c
Immunocytochemistry showing
expression of Kv7.2 (left) and
Kv7.3 (right) protein in
CTR33Qn1 hiPSC-derived
neurons at 19 dpp and 31 dpp
during neuronal differentiation, at
×20 and ×100, as indicated
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KCNQ5 remained elevated, whilst KCNQ2 expression waned
from 30 dpp onwards (Fig. 4a). With respect to absolute
quantitation of KCNQ mRNA, KCNQ2 and KCNQ3 were
expressed at significantly (p < 0.001) higher levels than
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Fig. 5 Spontaneous unit responses recorded from CTR33Qn1 hiPSC-
derived neurons plated in 24-well multi-electrode arrays (MEAs). a
Exemplars of 5-s snapshots of raw data taken from one electrode (position
24) within oneMEAwell. The first recording (left) is in the absence of drugs.
The subsequent recordings (right) are in the presence of GABAA receptor-
antagonist gabazine (5 μM), Kv7 channel opener retigabine (10 μM) and
Kv7 channel selective blocker XE991 (10 μM). b Histograms of spike rate
versus time for unit responses detected from individualMEA electrodes. Four
consecutive 120-s recording epochs are shown from two electrodes, position
24 (top) and position 43 (bottom). The first epoch is in the absence of drugs.
The inset shows 25 superimposed units detected during the first epoch. Drugs
were applied immediately before the recording.Gabazine (5μM)was applied
initially to increase spontaneous activity of CTR33Qn1 hiPSC-derived
neurons. Retigabine (10 μM) eliminated spiking and XE991 (10 μM)
restored spiking to a rate similar to that observed before introduction of
retigabine. c Bar charts presenting means of spike frequency ± SEM
measured in CTR33Qn1 hiPSC-derived neurons displayed significant
difference, determined by paired Student’s t test, in the presence of gabazine,
retigabine and XE991 (**p< 0.01) compared to the control in the absence of
drugs. A total of 11/12 electrodes detected units in this well and all responded
to retigabine. In 7 instances, activity returned in the presence of XE991
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KNCQ4 and KCNQ5 throughout the neuronal differentiation
period (Fig. 4b), suggesting that these two subunits may con-
tribute a quantitatively larger proportion to the outward cur-
rent, a notion supported by the robust expression of Kv7.2 and
Kv7.3 proteins during the differentiation protocol (Fig. 4c).
Spontaneous neural network activity that CTR33Qn1
hiPSC-derived neurons developed between 30 and 37 dpp
was recorded using MEAs. In the control, spontaneous neu-
ronal firing was 1.0 ± 0.3 Hz (n = 12), and similar to our pre-
vious study [37], pharmacological inhibition of GABAA re-
ceptors with gabazine (5 μM) resulted in a continuous and
significant increase in the rate of neuronal firing to 9.2 ±
2.3 Hz (n = 12; vs. control p < 0.01) (Fig. 5). Retigabine
(10 μM) suppressed gabazine induced firing to 0.8 ± 0.4 Hz
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Fig. 6 Forced expression of
Kv7.2/7.3 channel subunits
facilitates functional
maturation of in CTR33Qn1
hiPSC-derived neurons. a
Exemplar traces of current-clamp
recordings (injected current =
0 pA) for CTR33Qn1 hiPSC-
derived neurons exemplifying the
model activity of no activity
(Quiet), attempting activity
(Attempting) or spontaneous
activity (Spontaneous). b Bar
graphs showing percentage of
CTR33Qn1 hiPSC-derived
neurons exhibiting no activity
(Quiet), attempting activity
(Attempting) or spontaneous
activity (Spontaneous) (black
bars, left y-axis) and their mean
Vm (open bars, right y-axis) in
sham-transfected (left panels) and
Kv7.2/7.3 co-transfected
CTR33Qn1 hiPSC-derived
neurons (right panels) following
1, 2 and 3 weeks of in vitro
neuronal differentiation
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(n = 12; p < 0.01), and Kv7 channel selective blocker XE991
(10 μM) re-established the firing to 8.5 ± 2.5 Hz (n = 12; vs.
control p < 0.01) (Fig. 5).
Functional maturation and forced expression
of Kv7.2/7.3 channels in hiPSC-derived neurons
Based on the observations that KCNQ genes became highly
and differentially expressed in mouse striatum, human stria-
tum and hiPSC during in vivo and in vitro differentiation, the
effects of forced co-expression of the two subunits, Kv7.2 and
Kv7.3, known to constitute heteromeric Kv7 channel, were
investigated. This was carried out in an attempt to assess
whether such an experimental manoeuvre might accelerate
and/or synchronise the functional maturation of hiPSC-
derived neurons in order to provide a rational basis for enhanc-
ing current neuronal differentiation protocols. In these exper-
iments, we measured the individual Vm values and ongoing
electrical activity. For the latter, we classified hiPSC-derived
neurons in the same way we did in the previous study [37] as
showing absence of any activity (‘Quiet’), only sub-threshold
transient depolarizing events (‘Attempting’ activity) and ac-
tivity with overshooting action potentials (true ‘Spontaneous’
activity, Fig. 6a). Sham-transfected, pre-patterned,
CTR33Qn1-derived neurons showed rather little spontaneous
action potential generation during the first 2 weeks of neuro-
nal differentiation (6% (1/17) at week 1 and 7% (1/14) at week
2); this had risen to 56% (9/16) by week 3 (Fig. 6b, Table 1).
Forced co-expression of Kv7.2/7.3 resulted in a dramatic ac-
celeration of maturation, such that the proportion of spontane-
ously active neurons was augmented to 17% (3/18) at week 1,
31% (5/16) at week 2 and, most strikingly, 100% (12/12) at
week 3 (Fig. 6b, Table 1). These differences correlated well
with resting Vm.
This enhanced functional maturation could have resulted
from Kv7-dependent hyperpolarization or from other changes
in the resting or excitable membrane properties of the neurons.
To test this, we measured the initial resting Vm, then
neutralised any difference in potential by imposing a steady
hyperpolarization to − 70 mV, followed by 100-ms current
injection in order to induce action potentials; the effects of
dpp and Kv7.2/7.3 forced co-expression were determined sta-
tistically using two-way ANOVA. For Vm, there were signif-
icant effects of both Kv7.2/7.3 overexpression (p < 0.0001)
and weeks in vitro (p < 0.01). Indeed, by week 3, Vm of the
sham-transfected neurons had hyperpolarized to − 38.5 ± 1.7
(n = 16, p < 0.05), whilst that of the Kv7.2/7.3 overexpressing
neurons had hyperpolarized to − 45.5 ± 1.7 mV (n = 11, p <
0.05); this was 7 mV more negative than 3-week sham-
transfected neurons (p < 0.01). For Rin, there were significant
effects only of Kv7.2/7.3 overexpression (p < 0.02), presum-
ably reflecting enhanced M-current development; see further
below and Table 2.
The majority of CTR33Qn1-derived neurons, including
those at week 1, demonstrated robust induced action potentials
following an imposed depolarization from − 70 mV, with a
tendency towards more action potential trains as differentia-
tion proceeded (Table 3). However, there were no significant
effects of either weeks in vitro or Kv7.2/7.3 overexpression on
any of the induced action potential parameters (threshold,
overshoot, peak amplitude, afterhyperpolarization, peak rates
of depolarization and repolarization or half-width). Hence, the
simplest explanation for the increased spontaneous activity at
week 3 and its amplification on overexpressing Kv7.2/7.3
channels is that it results directly from the membrane hyper-
polarization, rather than from other changes in resting or ex-
citable properties.
In order to validate these data, experiments were performed
in an unrelated hiPCS line, 34D6. After 2 weeks of differen-
tiation, in those pre-patterned 34D6-derived neurons which
exhibited spontaneous activity, application of 10 μM of the
Kv7 channel opener, retigabine, resulted in reversible hyper-
polarizing responses which were significantly larger in the
Kv7.2/7.3 (− 7.7 ± 2.0 mV, n = 3) than in the sham group (−
5.4 ± 0.8 mV, n = 3, p < 0.03) and evoked a concomitantly
more pronounced attenuation in neuronal firing rate Fig. 7a,
b). At this point of neuronal differentiation, sham-transfected
34D6-derived neurons as a group exhibited a mean Vm of −
39.9 ± 2.2 (n = 12). Less than half (5/12) of this population,
with a mean membrane potential of − 47.2 ± 1.9 mV, showed
full spontaneous action potential activity (Fig. 7c). Of the
remainder, 2/12 (− 31.5 and − 36.4 mV) showed some sub-
threshold (‘Attempting’) activity, whilst 5/12 (mean Vm −
34.9 ± 2.9 mV) appeared totally quiet (Fig. 7c). Strikingly,
forced co-expression of Kv7.2/7.3 resulted in significant
Table 1 Proportions and percentages of sham-transfected (left) and
forced Kv7.2/7.3 co-expressing (+ Kv7.2/7.3, right) CTR33Qn1-
derived neurons which demonstrated each of the different types of
spontaneous action potentials (Quiet, Attempting or Spontaneous) during
weeks 1 (upper), 2 (middle) and 3 (lower) of neuronal differentiation post-
plate down in vitro
Week Activity type Sham transfected + Kv7.2/7.3
Proportion % Proportion %
1 Quiet 14/17 82 14/18 78
Attempting 2/17 12 1/18 5
Spontaneous 1/17 6 3/18 17
2 Quiet 8/14 57 5/16 31
Attempting 5/14 36 6/16 38
Spontaneous 1/14 7 5/16 31
3 Quiet 5/16 31 0/12 0
Attempting 2/16 13 0/12 0
Spontaneous 9/16 56 12/12 100
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hyperpolarization to a meanVm of − 51.3 ± 1.1 mV (n = 11, p
< 0.001), and now all of the cells showed full spontaneous
action potential activity (Fig. 7b, c). To underscore the impor-
tance of a hyperpolarised Vm to the functional maturation of
the neuronal network and gain further insight into its mecha-
nism of generation, activity was measured during artificial
hyperpolarisation by current injection. In those sham-
transfected neurons which did not exhibit spontaneous activity
(‘Quiet’), hyperpolarization of their Vm to − 70 mV resulted
in all neurons (11/11 neurons) firing repetitively, as exempli-
fied in Fig. 7d. Thus, these neurons clearly had the potential to
generate spontaneous activity yet lacked the mechanism re-
quired to bring Vm to a level sufficiently hyperpolarized to
remove Na+ channel inactivation; one such mechanism could
well be the regulated expression of Kv7 channels.
To address this point further, we recorded the Na+
currents during voltage-clamp in samples of sham-
transfected and Kv7.2/7.3 overexpressing CTR33Qn1-
derived neurons at weeks 1, 2 and 3 in culture
(Fig. 8a). By two-way ANOVA, there were no significant
effects of weeks in vitro or Kv7.2/7.3 overexpression
(Fig. 8b). However, the progressive hyperpolarization,
which occurred during differentiation, and which was
enhanced by over co-expression of the Kv7.2/7.3 chan-
nels, brought resting Vm values within the range of over-
lap between the Na+ activation and inactivation curves
Table 2 Analysis of passive and active parameters of induced action potentials from sham-transfected (left) and forced Kv7.2/7.3 co-expressing (right)
CTR33Qn1-derived neurons during 1 (upper), 2 (middle) and 3 (lower) weeks of neuronal differentiation post-plate down in vitro
Week Action potential parameters Sham transfected + Kv7.2/7.3
Mean SEM n Mean SEM n
1 Passive Vm (mV) − 30.2 1.8 17 − 30.9 2.0 20
Rin (GΩ) 1.65 0.14 16 1.12 0.11 17
Cp (pF) 14.1 2.0 13 13.7 1.4 15
Spike analysis Threshold (mV) − 30.6 2.4 16 − 27.9 1.7 16
Overshoot (mV) 29.0 4.5 16 25.2 4.0 16
Afterhyperpolarization (mV) − 57.0 4.3 16 − 54.3 2.7 16
Amplitude (mV) 86.0 6.4 16 79.5 5.2 16
Depolarization rate (V/s) 70.0 12.2 16 62.3 9.9 16
Repolarization rate (V/s) − 49.6 9.5 16 − 38.6 6.7 16
Half-width (ms) 2.9 0.4 16 3.1 0.3 16
2 Passive Vm (mV) − 31.4 2.3 14 − 37.8 2.6 16
Rin (GΩ) 1.36 0.19 12 0.88 0.12 11
Cp (pF) 10.9 2.8 8 17.5 4.2 9
Spike analysis Threshold (mV) − 38.0 3.0 12 − 30.9 3.2 11
Overshoot (mV) 33.2 6.9 12 37.4 6.9 11
Afterhyperpolarization (mV) − 64.3 5.7 12 − 56.1 2.4 11
Amplitude (mV) 97.5 11.6 12 93.5 6.7 11
Depolarization rate (V/s) 83.0 14.0 12 94.2 18.4 11
Repolarization rate (V/s) − 56.2 12.6 12 − 45.8 8.8 11
Half-width (ms) 3.0 0.5 12 2.8 0.3 11
3 Passive Vm (mV) − 38.5** 1.7 16 − 45.5** 1.7 11
Rin (GΩ) 0.79 0.06 12 0.61 0.05 10
Cp (pF) 17.1 2.8 11 16.3 2.5 10
Spike analysis Threshold (mV) − 33.0 2.5 12 − 32.4 3.9 10
Overshoot (mV) 34.19 5.1 12 42.2 3.8 10
Afterhyperpolarization (mV) − 56.0 5.2 12 − 60.7 2.9 10
Amplitude (mV) 90.2 7.8 12 102.9 3.3 10
Depolarization rate (V/s) 84.8 10.5 12 104.7 10.0 10
Repolarization rate (V/s) − 40.9 5.0 12 − 49.4 6.4 10
Half-width (ms) 3.0 0.6 12 2.9 0.6 10
Vm membrane potential, Rin input resistance, Cp whole-cell capacitance
**Significantly different from each other at p < 0.01
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(Fig. 8c–h), thus removing enough of the steady-state
inactivation to facilitate action potential generation.
Discussion
The role of ion channels in neurogenesis and stem cell devel-
opment has been quite extensively studied. Evidence has been
provided for a role of CaV3.1 voltage-gated L-type Ca
2+ chan-
nels in the differentiation of neural stem/progenitor cells [9]
and of Kv3.1 K+ channels in the proliferation and neuronal
differentiation of adult neural precursor cells [43]. Expression
of Kv7.4 channels was recently reported in neurons derived
from embryonic stem cells [28], and a potential role of Kv7.2/
7.3 channels in differentiation, synaptogenesis and synaptic
function of mouse hippocampal and embryonic stem cell-
derived neurons has been indicated [44].
In the present study, we explored the role of Kv7 (Kv7.2/
7.3) channels in the development and neuronal differentiation
in mouse striatum and in the functional maturation of hiPSC-
derived neurons. In the striatal neurons, we found a close
correlation between the hyperpolarization of Vm, the expres-
sion of Kv7 channel subunit proteins both in vivo, between
embryonic stages E13 and E17, and subsequently when cul-
tured in vitro. Crucially, expression of mRNA encoding Kv7
subunits in the human developing striatum demonstrated a
very similar ontogeny. Likewise, in the hiPSC-derived neu-
rons, we observed a comparable relation between Kv7 chan-
nel expression and the development of normal excitable
activity. In this latter case, at least, this relationship is likely
to have been causal because the development of excitability
was enhanced by overexpression of the Kv7.2/Kv7.3
heteromeric channels.
In addition to the increased overall Kv7 channel expres-
sion, another factor which might favour the increasing influ-
ence of the Kv7 channels in the maturation of the mouse
MSNs could be the progressive switch from homomeric
Kv7.2 to heteromeric Kv7.2/7.3 channels as suggested by
the qPCR experiments. Since the heteromer has a higher af-
finity for the membrane phospholipid phosphatidylinositol-
4,5-bisphosphate (PIP2) [21, 36], which is required for Kv7
channel opening, this itself might lead to a progressively larg-
er current and increased membrane potential during develop-
ment. In the hiPSC-derived neurons, the switch may be to-
wards more Kv7.5 (KCNQ5), a subunit highly enriched in the
adult striatum and which is a robust marker for human MSNs,
as described in the Allen Human Brain Atlas (http://human.
brain-map.org.).
The Kv7-driven membrane hyperpolarization would itself
favour the expression of excitable properties, as indicated by
the increased spontaneous activity of the developing hiPSC-
derived neurons during a brief imposed hyperpolarization.
Mechanistically, the key effect of developmental or imposed
upregulation of the Kv7 channels was to bring the resting
membrane potential within the optimal range for Na+ channel
activation where activation and inactivation parameters over-
lap (and hence favour spontaneous action potential firing),
without any change in the amplitude or kinetic parameters of
Table 3 Proportion (%) of sham-
transfected (left) and forced
Kv7.2/7.3 co-expressing (right)
CTR33Qn1-derived neurons
which demonstrated each of the
different types of induced action
potentials during weeks 1 (upper),
2 (middle) and 3 (lower) weeks of
neuronal differentiation post-plate
down in vitro
Week Induced action potential type Sham transfected + Kv7.2/7.3
Proportion % Proportion %
1 None 1/17 6 0/16 0
Attempting single 0/17 0 0/16 0
Single 5/17 29 4/16 25
Attempting train 1/17 6 3/16 19
Train 10/17 59 9/16 56
2 None 0/12 0 0/11 0
Attempting single 0/12 0 0/11 0
Single 3/12 25 2/11 18
Attempting train 1/12 8 2/11 18
Train 8/12 67 7/11 64
3 None 0/12 0 0/11 0
Attempting single 0/12 0 0/11 0
Single 3/12 25 0/11 0
Attempting train 0/12 0 0/11 0
Train 9/12 75 0/11 100
None = no significant voltage excursions from baseline; Attempting single = voltage excursions which do not
overshoot 0 mV; Single = one excursion only, but which overshoots 0 mV; Attempting train = several excursions,
but only one which overshoots 0 mV; Train = several excursions, with more than one which overshoots 0 mV
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the Na+ current or action potential themselves. However, fur-
ther effects on the developmental process itself might well
result from, for example, increased Ca2+ entry through co-
activated voltage-gated Ca2+channels [9, 29] or an increased
gradient for Ca2+ influx via other mechanisms. Further, K+
channels are known to be involved in the proliferation of
non-excitable cells such as T lymphocytes [10] and a variety
of tumour cells [16], through mechanisms that are not yet
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Fig. 7 Forced expression of
Kv7.2/7.3 channels facilitates
functional maturation of 34D6
hiPSC-derived neurons. a
Pharmacological identification of
Kv7.2/7.3 channels (retigabine-
activated) in an exemplar
(injected current = 0 pA), sham-
transfected, spontaneously active
34D6 hiPSC-derived neuron
following 2 weeks of in vitro
neuronal differentiation. Vm was
measured in current-clamp mode
of the whole-cell patch-clamp
configuration in the absence and
presence of 10 μM retigabine
(indicated above themain trace by
a transparent box). Below the
trace are extracted action potential
events shown on a fester time
base. b Pharmacological
identification of Kv7.2/7.3
channels (retigabine-activated) in
an exemplar (injected current =
0 pA), Kv7.2/7.3 co-transfected,
spontaneously active 34D6
hiPSC-derived neuron following
2 weeks of in vitro neuronal
differentiation. Recording and
display parameters as in a. c Bar
graphs showing percentage of
34D6 hiPSC-derived neurons
exhibiting no activity (Quiet),
attempting activity (Attempting)
or spontaneous activity
(Spontaneous) (black bars, left y-
axis) and their mean Vm (open
bars, right y-axis) in sham-
transfected (left panel) and Kv7.2/
7.3 co-transfected 34D6 hiPSC-
derived neurons (right panel)
following 2 weeks of in vitro
neuronal differentiation. d
Neuronal activity in an exemplar
in untransfected quiet 34d6
hiPSC-derived neuron following
2 weeks of differentiation evoked
by artificial current injection to
bring Vm below − 50 mV
(indicated by a black bar above
the main trace). Recording and
display parameters as in a
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entirely clear; and Kv7.4 channels also appear to regulate
skeletal muscle development [17].
The results presented herein show that an adequate expres-
sion of Kv7 channels in striatal and hiPSC-derived neurons is
vital for functional maturation, demonstrating their crucial
role in the normal development and maturation of striatal neu-
rons and of hiPSC-derived striatal neurons. This knowledge
can now be harnessed and applied to any pre-patterned neu-
ronal precursor to synchronise and accelerate neuronal differ-
entiation in order to generate meaningful, disease-relevant
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neurons for high-throughput screening and drug discovery for
pathologies characterised by neural loss or degeneration.
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